Key facts
- Notable investors include High-Tech Gründerfonds, V-Bio Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for TRIM TX
- ·The full record, as it builds
Funding rounds
No funding rounds for TRIM TX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TRIM TX
Developer of gamma-secretase stabilizers designed to prevent and treat Alzheimer's disease. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- Gent, Belgium
- Founded
- 2024
- Ownership
- Privately Held (backing)
TRIM TX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TRIM TX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TRIM TX in its N-PORT filings yet. We sweep new filings monthly.